Clinical Trial Update: Geographic Atrophy Treatment Evaluation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a treatment for geographic atrophy associated with age-related macular degeneration conducted by Alcon was terminated, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Snippet

Sponsor: Alcon Research | Conditions: Geographic Atrophy, Age-Related Macular Degeneration | Phase 3 | Status: TERMINATED | Results posted: 2014-07-03